Oral molnupiravir at higher dose reduces SARS-CoV-2 viral load at day five in small phase 2 study
HIV Treatment Bulletin
; 22:9-10, 2021.
Article
in English
| Africa Wide Information | ID: covidwho-1661023
ABSTRACT
WATERLIT Results from a double-blind, randomised, placebo-controlled, phase 2 dose-range finding study reported faster viral load clearance after five days using oral molnupiravir at the highest dose
Search on Google
Collection:
Databases of international organizations
Database:
Africa Wide Information
Language:
English
Journal:
HIV Treatment Bulletin
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS